<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18027/2224-5057-2020-10-3-20-25</article-id><article-id custom-type="elpub" pub-id-type="custom">tumors-811</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СОБСТВЕННЫЕ ИССЛЕДОВАНИЯ. ВОПРОСЫ ОНКОХИРУРГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OWN RESEARCH. ONCOSURGERY ISSUES</subject></subj-group></article-categories><title-group><article-title>Хирургическое лечение местно-распространенного рака вульвы</article-title><trans-title-group xml:lang="en"><trans-title>Surgical treatment of locally advanced vulvar cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мухин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukhin</surname><given-names>A.  A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Арсентий А. Мухин, врач-онколог онкологического гинекологического отделения</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Arsentiy A. Mukhin, Oncologist, Department of Gynaecological Oncology </p><p>Chelyabinsk</p></bio><email xlink:type="simple">pobokon@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Важенин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vazhenin</surname><given-names>A.  V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей В. Важенин, д. м. н., профессор, заслуженный врач РФ, академик РАН, заведующий кафедрой онкологии, лучевой диагностики и лучевой терапии ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России, главный врач ГБУЗ «Челябинский областной клинический центр онкологии и ядерной медицины»</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Andrey V. Vazhenin, MD, PhD, DSc, Prof., Honoured Doctor of the Russian Federation, Academician of the Russian Academy of Sciences, Head, Department of Oncology, Radiation Diagnostics, and Radiation Therapy, South Ural State Medical University of the Ministry of Health of the Russian Federation, Physician-in-Chief, Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine</p><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саевец</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Saevets</surname><given-names>V.  V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валерия В. Саевец, к. м. н., заведующая онкологического гинекологического отделения</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Valeriya V. Saevets, MD, PhD, Head of the Department of Gynaecological Oncology</p><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Таратонов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Taratonov</surname><given-names>A.  V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей В. Таратонов, врач-онколог онкологического гинекологического отделения</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Aleksey V. Taratonov, Oncologist, Department of Gynaecological Oncology </p><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский областной клинический центр онкологии и ядерной медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Челябинский областной клинический центр онкологии и ядерной медицины»; ФГБОУ ВО «Южно-Уральский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine; South Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>04</month><year>2021</year></pub-date><volume>10</volume><issue>3</issue><fpage>20</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мухин А.А., Важенин А.В., Саевец В.В., Таратонов А.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Мухин А.А., Важенин А.В., Саевец В.В., Таратонов А.В.</copyright-holder><copyright-holder xml:lang="en">Mukhin A.A., Vazhenin A.V., Saevets V. ., Taratonov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/811">https://www.malignanttumors.org/jour/article/view/811</self-uri><abstract><p>В статье рассмотрена возможность выполнения хирургического лечения больных с местно-распространенным раком вульвы в зависимости от объема удаляемых тканей и возможности реконструктивно-пластического компонента. Приведены положительные и отрицательные стороны различных хирургических реконструктивно-пластических методик. Вопрос о закрытии раневого дефекта после вульвэктомии и проведении пластики всегда вызывал неоднозначные споры различных авторов и привел к усложнению пластического компонента, а также снижению показаний или отказу от данного вида операции.</p></abstract><trans-abstract xml:lang="en"><p>The article discusses the choice of different surgical procedures in patients with locally advanced vulvar cancer, depending on the volume of resected tissues and the possibility of reconstructive plastic surgery. The advantages and disadvantages of various plastic reconstructive techniques are provided. The issue of wound closing after the vulvectomy and the plastic techniques has always been controversial and led to the sophistication of the reconstructive component, as well as to the limitations or refusal of this surgical procedure use.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак вульвы</kwd><kwd>реконструктивно-пластический компонент</kwd><kwd>вульвэктомия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>vulvar cancer</kwd><kwd>reconstructive plastic surgery</kwd><kwd>vulvectomy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бохман Я. В., 1989; Таджибаева Ю. Т., 1990; Жаров A. B., 1995; Кузнецов В. В., Мехтиев В. Н., Коржевская Е. В. и соавт. 2000; Хасанов A. A., 2000).</mixed-citation><mixed-citation xml:lang="en">Бохман Я. В., 1989; Таджибаева Ю. Т., 1990; Жаров A. B., 1995; Кузнецов В. В., Мехтиев В. Н., Коржевская Е. В. и соавт. 2000; Хасанов A. A., 2000).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007; 31:1077–1085.</mixed-citation><mixed-citation xml:lang="en">Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007; 31:1077–1085.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation techni-que is used. Int J Radiat Oncol Biol Phys 1993; 27: 963–967.</mixed-citation><mixed-citation xml:lang="en">Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation techni-que is used. Int J Radiat Oncol Biol Phys 1993; 27: 963–967.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Greer BE, Koh WJ. New NCCN Guidelines for Vulvar Cancer. J Natl Compr Canc Netw 2016; 14:656–658.</mixed-citation><mixed-citation xml:lang="en">Greer BE, Koh WJ. New NCCN Guidelines for Vulvar Cancer. J Natl Compr Canc Netw 2016; 14:656–658.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
